Page 13 - Agl News Today

Australia exports most of its coal and gas, and prices have skyrocketed. We could be facing a winter of pain for gas users.

AGL’s demerger backflip has been labelled “the most bungled and misguided” attempt at a corporate restructure in Australian history. On Monday morning, Australia’s biggest domestic contribut

HESTA has welcomed the decision by AGL to scrap its de-merger plan, after spending an estimated $160 million, and the chief executive and chairman resigned.

AGL is a failure of stewardship, according to the CEO of Climate Energy Finance. Speaking at the Stockbrokers and Investment Advisers recent conference, Tim Buckley explained that the transition tow

HESTA has announced it will vote against AGL’s demerger proposal as it believes it will not adequately support economy-wide decarbonisation and will not be in the best interests of members.

ANGLE (LON:AGL – Get Rating)‘s stock had its “buy” rating reissued by investment analysts at Berenberg Bank in a research note issued to investors on Monday, Digital Look reports. They presently have a GBX 195 ($2.45) price target on the stock. Berenberg Bank’s price target suggests a potential upside of 98.98% from the stock’s previous […]

Agilon health (NYSE:AGL – Get Rating) and Curative Biotechnology (OTCMKTS:CUBT – Get Rating) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, earnings, dividends and institutional ownership. Analyst Ratings This is a breakdown of current ratings and […]

Agilon health (NYSE:AGL – Get Rating) and Curative Biotechnology (OTCMKTS:CUBT – Get Rating) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, earnings, profitability, valuation and dividends. Institutional & Insider Ownership 96.2% of agilon health shares are […]

Agilon health, inc. (NYSE:AGL – Get Rating) has earned a consensus recommendation of “Buy” from the eight analysts that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12 month price objective […]

AGL Energy is determined to go ahead with the planned demerger despite Mike Cannon-Brookes purchase which has made the tech billionaire the company’s largest single shareholder. In an ASX listing on